HomeCompareCSII vs DIVO

CSII vs DIVO: Dividend Comparison 2026

CSII yields 10.00% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSII wins by $7.8K in total portfolio value
10 years
CSII
CSII
● Live price
10.00%
Share price
$20.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.8K
Annual income
$1,874.61
Full CSII calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — CSII vs DIVO

📍 CSII pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSIIDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSII + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSII pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSII
Annual income on $10K today (after 15% tax)
$850.00/yr
After 10yr DRIP, annual income (after tax)
$1,593.42/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, CSII beats the other by $736.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSII + DIVO for your $10,000?

CSII: 50%DIVO: 50%
100% DIVO50/50100% CSII
Portfolio after 10yr
$34.9K
Annual income
$1,441.54/yr
Blended yield
4.13%
📊

Analyst Conviction Gap

Where Wall Street is split right now

CSII
Analyst Ratings
1
Hold
Consensus: Hold
Price Target
$17.50
-12.5% upside vs current
Range: $15.00 — $20.00
Altman Z
6.1
Piotroski
5/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSII buys
0
DIVO buys
0
No recent congressional trades found for CSII or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSIIDIVO
Forward yield10.00%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$38.8K$31.0K
Annual income after 10y$1,874.61$1,008.47
Total dividends collected$14.3K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CSII vs DIVO ($10,000, DRIP)

YearCSII PortfolioCSII Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$11,700$1,000.00$11,362$661.96+$338.00CSII
2$13,612$1,093.46$12,860$702.91+$752.00CSII
3$15,754$1,188.96$14,504$743.56+$1.3KCSII
4$18,143$1,286.02$16,303$783.73+$1.8KCSII
5$20,797$1,384.13$18,268$823.31+$2.5KCSII
6$23,736$1,482.82$20,408$862.17+$3.3KCSII
7$26,979$1,581.62$22,737$900.20+$4.2KCSII
8$30,548$1,680.12$25,266$937.31+$5.3KCSII
9$34,464$1,777.90$28,008$973.42+$6.5KCSII
10$38,751$1,874.61$30,977$1,008.47+$7.8KCSII

CSII vs DIVO: Complete Analysis 2026

CSIIStock

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

Full CSII Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CSII vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSII vs SCHDCSII vs JEPICSII vs OCSII vs KOCSII vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.